Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 401 to 450 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
401\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
M-PHASE INDUCER PHOSPHATASE 3 (EC 3.1.3.48) (DUAL SPECIFICITY PHOSPHATASE CDC25C). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.590395\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.12136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278309669\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CDC25C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CENTAURIN GAMMA 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0439645\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.158002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278252807\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CENTG1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
403\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CENTAURIN GAMMA 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0479426\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.172299\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.27825234\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CENTG2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GENERAL VESICULAR TRANSPORT FACTOR P115 (TRANSCYTOSIS ASSOCIATED PROTEIN) (TAP) (VESICLE DOCKING PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.73296\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6.22802\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278252157\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
USO1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CENTAURIN GAMMA 3. \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0546138\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.196275\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.278251433\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
CENTG3\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
406\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
MOSC1\vspace{3pt}}\\\cline{1-1}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
407\vspace{3pt}}&&&&&\parbox{\wcF}{\vspace{3pt}\noindent
MOSC2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE PRE-MRNA SPLICING FACTOR RNA HELICASE (DEAH BOX PROTEIN 15) (ATP-DEPENDENT RNA HELICASE #46). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.603245\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.16897\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278125101\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DHX15\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"BA138E2.1.2 (FORMIN-BINDING PROTEIN 17 (FBP17), ISOFORM 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.404169\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.45394\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277981897\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FNBP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EYES ABSENT HOMOLOG 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2.06651\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7.43888\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.27779854\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EYA3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.356784\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.28488\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277678849\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARGININE/SERINE-RICH SPLICING FACTOR 10 (TRANSFORMER-2-BETA) (HTRA2- BETA) (TRANSFORMER 2 PROTEIN HOMOLOG) (SILICA-INDUCED PROTEIN 41) (RA301). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.368948\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.32916\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277579825\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SFRS10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.197804\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.712745\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.27752422\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CCDC49\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SAL-LIKE PROTEIN 2 (ZINC FINGER PROTEIN SALL2) (HSAL2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.13272\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.478487\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277374307\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SALL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
415\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SAL-LIKE PROTEIN 4 (ZINC FINGER PROTEIN SALL4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.135171\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.487324\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277373985\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SALL4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
416\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CLATHRIN COAT ASSEMBLY PROTEIN AP180 (CLATHRIN COAT ASSOCIATED PROTEIN AP180) (91 KDA SYNAPTOSOMAL-ASSOCIATED PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.212723\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.766919\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277373491\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SNAP91\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATROPHIN-1 (DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.13427\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.484077\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277373228\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATN1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0384193\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.138512\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277371636\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C8orf79\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SAL-LIKE PROTEIN 3 (ZINC FINGER PROTEIN SALL3) (HSALL3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.148125\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.534032\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277371019\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SALL3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
420\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLYPYRIMIDINE TRACT BINDING PROTEIN 2; NEURAL POLYPYRIMIDINE TRACT BINDING PROTEIN; PTB-LIKE PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.152427\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.549542\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277370974\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PTBP2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
421\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 8 (EC 3.1.2.15) (UBIQUITIN THIOLESTERASE 8) (UBIQUITIN-SPECIFIC PROCESSING PROTEASE 8) (DEUBIQUITINATING ENZYME 8). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0884444\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.318867\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277370816\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
USP8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ROD1 REGULATOR OF DIFFERENTIATION 1; FISSION YEAST DIFFERENTIATION REGULATOR; REGULATOR OF DIFFERENTIATION (IN S. POMBI) 1; REGULATOR OF DIFFERENTIATION (IN S. POMBE) 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.153277\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.552607\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277370717\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ROD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADAPTOR-ASSOCIATED KINASE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.168547\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.60766\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277370569\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AAK1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0397949\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.143472\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277370497\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARHGAP23\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DEAD (ASP-GLU-ALA-ASP) BOX POLYPEPTIDE 47; HQP0256 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0884193\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.318777\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277370387\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
426\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHO-GTPASE ACTIVATING PROTEIN 10. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0500251\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.180355\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277370187\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARHGAP21\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
427\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GROWTH-ARREST-SPECIFIC PROTEIN 7 (GAS-7). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.139845\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.504182\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277370077\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GAS7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
428\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHATIDYLINOSITOL-BINDING CLATHRIN ASSEMBLY PROTEIN (CLATHRIN ASSEMBLY LYMPHOID MYELOID LEUKEMIA PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.276961\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.998529\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.27736901\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PICALM\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
429\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SAL-LIKE PROTEIN 1 (ZINC FINGER PROTEIN SALL1) (SPALT-LIKE TRANSCRIPTION FACTOR 1) (HSAL1). \vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.176985\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.63809\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.277366829\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
SALL1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
430\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 4; NOT4 (NEGATIVE REGULATOR OF TRANSCRIPTION 4, YEAST) HOMOLOG; CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
CNOT4\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
431\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARGININE-GLUTAMIC ACID DIPEPTIDE (RE) REPEATS; ATROPHIN 1-LIKE; ARGININE GLUTAMIC ACID DIPEPTIDE RE REPEATS. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
RERE\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
432\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"2-OXOISOVALERATE DEHYDROGENASE BETA SUBUNIT, MITOCHONDRIAL PRECURSOR (EC 1.2.4.4) (BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE E1 COMPONENT BETA CHAIN) (BCKDH E1-BETA). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
BCKDHB\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
433\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLYPYRIMIDINE TRACT-BINDING PROTEIN 1 (PTB) (HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN I) (HNRNP I) (57 KDA RNA-BINDING PROTEIN PPTB-1). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
PTBP1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
434\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEMBRANE-ASSOCIATED NUCLEIC ACID BINDING PROTEIN. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
RC3H2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
435\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EYES ABSENT HOMOLOG 4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.76157\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6.35359\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277255851\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EYA4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
436\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EYES ABSENT HOMOLOG 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.76022\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6.35074\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2771677\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EYA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
437\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EYES ABSENT HOMOLOG 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.69676\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6.12181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.277166394\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EYA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
438\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSFORMER-2 PROTEIN HOMOLOG (TRA-2 ALPHA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.345566\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.24774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.276953532\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
439\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AF-6 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.263953\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.953667\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.276776904\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MLLT4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
440\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLUTATHIONE S-TRANSFERASE THETA 2 (EC 2.5.1.18) (GST CLASS-THETA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.182551\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.659693\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.276721142\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GSTT2B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
441\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATPASE INHIBITOR, MITOCHONDRIAL PRECURSOR. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0602832\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.217862\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.276703601\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATPIF1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
442\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLYAMINE OXIDASE ISOFORM 1; POLYAMINE OXIDASE; FLAVIN-CONTAINING SPERMINE OXIDASE; PUTATIVE CYCLIN G1 INTERACTING PROTEIN; FLAVIN CONTAINING AMINE OXIDASE. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
SMOX\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
443\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEROXISOMAL N1-ACETYL-SPERMINE/SPERMIDINE OXIDASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0442587\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.15995\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.276703345\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PAOX\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
444\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYTOCHROME C-TYPE HEME LYASE (EC 4.4.1.17) (CCHL) (HOLOCYTOCHROME C- TYPE SYNTHASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0485005\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.17528\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.27670299\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HCCS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
445\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLUTATHIONE S-TRANSFERASE THETA 1 (EC 2.5.1.18) (GST CLASS-THETA) (GLUTATHIONE TRANSFERASE T1-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.230886\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.83446\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.276689116\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GSTT1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
446\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.260039\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.939933\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.276656953\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NPLOC4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
REGUCALCIN GENE PROMOTOR REGION RELATED PROTEIN; RGPR-P117. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.109365\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.395349\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.276629004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEC16B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
448\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.141581\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.511852\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.276605347\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEC16A\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
449\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0621484\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.224949\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.276277734\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TSNARE1\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
450\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0374708\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.135742\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.27604426\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ISY1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/